The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: A real-world analysis of outcomes, clinical and pathologic characteristics.
 
Thais Baccili Cury Megid
No Relationships to Disclose
 
Zeynep Baskurt
No Relationships to Disclose
 
Lucy Xiaolu Ma
No Relationships to Disclose
 
Carly C. Barron
No Relationships to Disclose
 
Marie-Philippe Saltiel
No Relationships to Disclose
 
Abdul Rehman Farooq
No Relationships to Disclose
 
Raymond Woo-Jun Jang
No Relationships to Disclose
 
Eric Xueyu Chen
Honoraria - AstraZeneca Canada; Bayer; Eisai; Ipsen
Research Funding - 1Globe Health Institute; AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Sharp & Dohme; Mirati Therapeutics; Novartis; Nubiyota; Repare Therapeutics; Roche Canada
 
Rebecca KS Wong
Honoraria - Elekta (Inst); Novartis
Research Funding - Bruce Power (Inst); Celgene/Bristol-Myers Squibb (Inst)
 
Aruz Mesci
No Relationships to Disclose
 
Hiroko Aoyama
No Relationships to Disclose
 
Yvonne Bach
No Relationships to Disclose
 
Xin Wang
No Relationships to Disclose
 
Patrick Veit-Haibach
No Relationships to Disclose
 
Ben X Wang
No Relationships to Disclose
 
Sangeetha Kalimuthu
No Relationships to Disclose
 
James Cotton
No Relationships to Disclose
 
Elena Elimova
Employment - Merck (I)
Consulting or Advisory Role - Adaptimmune (Inst); Astellas Pharma; BeiGene (Inst); Bristol-Myers Squibb (Inst); Viracta Therapeutics; Zymeworks (Inst)
Research Funding - AstraZeneca Canada (Inst); Bold Therapeutics (Inst); Bristol-Myers Squibb (Inst); Zymeworks (Inst)